Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$10.8M Buy
304,453
+5,438
+2% +$202K 0.01% 1394
2014
Q2
$11.7M Buy
299,015
+13,513
+5% +$505K 0.01% 1248
2014
Q1
$10.4M Buy
285,502
+477
+0.2% +$17.4K 0.01% 1237
2013
Q4
$9.86M Buy
285,025
+4,239
+2% +$136K 0.01% 1259
2013
Q3
$7.84M Buy
280,786
+19,236
+7% +$513K 0.01% 1319
2013
Q2
$7.05M Buy
+261,550
New +$7.22M 0.01% 1311

Other funds holding XYL

UBS's XYL Position: Q3 2014 in Review

UBS increased its Xylem (XYL) stake by 1.8% in Q3 2014, buying an estimated $202K and bringing the position to 304,453 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1394.

UBS first reported a position in XYL in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • UBS held 304,453 shares of Xylem worth $10.8M as of Q3 2014.
  • UBS bought 5,438 Xylem shares in Q3 2014, an estimated $202K.
  • Xylem made up 0.01% of UBS's portfolio in Q3 2014, its #1394 holding.
  • UBS first reported a position in Xylem in Q2 2013 and has held it in 6 quarters since.
  • UBS's Xylem position peaked at $11.7M in Q2 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.